| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.56e-05 | 37 | 48 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.45e-04 | 127 | 48 | 4 | GO:0008094 | |
| MousePheno | impaired muscle contractility | 1.31e-05 | 297 | 38 | 7 | MP:0000738 | |
| MousePheno | absent skeletal muscle | 7.16e-05 | 5 | 38 | 2 | MP:0004846 | |
| MousePheno | abnormal muscle contractility | 1.15e-04 | 418 | 38 | 7 | MP:0005620 | |
| MousePheno | abnormal Z line morphology | 1.71e-04 | 40 | 38 | 3 | MP:0004091 | |
| MousePheno | abnormal I band morphology | 1.98e-04 | 42 | 38 | 3 | MP:0030567 | |
| Domain | CH | 1.19e-06 | 73 | 48 | 5 | PS50021 | |
| Domain | CH-domain | 1.36e-06 | 75 | 48 | 5 | IPR001715 | |
| Domain | CHDCT2 | 1.94e-05 | 3 | 48 | 2 | PF08074 | |
| Domain | CHDNT | 1.94e-05 | 3 | 48 | 2 | PF08073 | |
| Domain | DUF1086 | 1.94e-05 | 3 | 48 | 2 | IPR009462 | |
| Domain | DUF1087 | 1.94e-05 | 3 | 48 | 2 | IPR009463 | |
| Domain | CHD_N | 1.94e-05 | 3 | 48 | 2 | IPR012958 | |
| Domain | CHD_C2 | 1.94e-05 | 3 | 48 | 2 | IPR012957 | |
| Domain | DUF1087 | 1.94e-05 | 3 | 48 | 2 | PF06465 | |
| Domain | DUF1086 | 1.94e-05 | 3 | 48 | 2 | PF06461 | |
| Domain | DUF1087 | 1.94e-05 | 3 | 48 | 2 | SM01147 | |
| Domain | DUF1086 | 1.94e-05 | 3 | 48 | 2 | SM01146 | |
| Domain | CH | 2.32e-05 | 65 | 48 | 4 | SM00033 | |
| Domain | CH | 3.11e-05 | 70 | 48 | 4 | PF00307 | |
| Domain | - | 3.29e-05 | 71 | 48 | 4 | 1.10.418.10 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 9.84e-05 | 35 | 48 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.26e-04 | 38 | 48 | 3 | PS00690 | |
| Domain | SM22_calponin | 3.51e-04 | 11 | 48 | 2 | IPR003096 | |
| Domain | Zinc_finger_PHD-type_CS | 6.22e-04 | 65 | 48 | 3 | IPR019786 | |
| Domain | PHD | 9.45e-04 | 75 | 48 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 1.10e-03 | 79 | 48 | 3 | IPR019787 | |
| Domain | PHD | 1.55e-03 | 89 | 48 | 3 | SM00249 | |
| Domain | Actinin_actin-bd_CS | 1.58e-03 | 23 | 48 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 1.58e-03 | 23 | 48 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.58e-03 | 23 | 48 | 2 | PS00019 | |
| Domain | Znf_PHD | 1.65e-03 | 91 | 48 | 3 | IPR001965 | |
| Domain | Chromo_domain | 1.72e-03 | 24 | 48 | 2 | IPR023780 | |
| Domain | ZF_PHD_2 | 1.87e-03 | 95 | 48 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 1.92e-03 | 96 | 48 | 3 | PS01359 | |
| Domain | Chromo | 2.02e-03 | 26 | 48 | 2 | PF00385 | |
| Domain | CHROMO_1 | 2.34e-03 | 28 | 48 | 2 | PS00598 | |
| Domain | CHROMO_2 | 2.34e-03 | 28 | 48 | 2 | PS50013 | |
| Domain | - | 2.79e-03 | 746 | 48 | 7 | 3.40.50.300 | |
| Domain | SNF2_N | 3.05e-03 | 32 | 48 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 3.05e-03 | 32 | 48 | 2 | IPR016197 | |
| Domain | SNF2_N | 3.05e-03 | 32 | 48 | 2 | PF00176 | |
| Domain | Chromo/shadow_dom | 3.25e-03 | 33 | 48 | 2 | IPR000953 | |
| Domain | CHROMO | 3.25e-03 | 33 | 48 | 2 | SM00298 | |
| Domain | P-loop_NTPase | 5.63e-03 | 848 | 48 | 7 | IPR027417 | |
| Domain | - | 5.75e-03 | 449 | 48 | 5 | 3.30.40.10 | |
| Domain | EF-hand-dom_pair | 6.25e-03 | 287 | 48 | 4 | IPR011992 | |
| Domain | Znf_RING/FYVE/PHD | 6.30e-03 | 459 | 48 | 5 | IPR013083 | |
| Domain | Znf_FYVE_PHD | 6.38e-03 | 147 | 48 | 3 | IPR011011 | |
| Pubmed | FLNA CHD3 CHD4 DST ACACB LMO7 SPEF2 RBFA PRRC2B FBF1 STARD10 RSF1 | 4.29e-07 | 1442 | 48 | 12 | 35575683 | |
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 1.87e-06 | 2 | 48 | 2 | 7560064 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 7575689 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 1.87e-06 | 2 | 48 | 2 | 35568926 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 1.87e-06 | 2 | 48 | 2 | 8843877 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.57e-06 | 157 | 48 | 5 | 30686591 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 32658897 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 9326634 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 16574654 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 11829485 | ||
| Pubmed | DIPK2A promotes STX17- and VAMP7-mediated autophagosome-lysosome fusion by binding to VAMP7B. | 1.86e-05 | 5 | 48 | 2 | 31251111 | |
| Pubmed | 2.33e-05 | 418 | 48 | 6 | 34709266 | ||
| Pubmed | Chromatin remodeling proteins interact with pericentrin to regulate centrosome integrity. | 2.79e-05 | 6 | 48 | 2 | 17626165 | |
| Pubmed | 3.35e-05 | 446 | 48 | 6 | 24255178 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.82e-05 | 934 | 48 | 8 | 33916271 | |
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 5.19e-05 | 8 | 48 | 2 | 10655032 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 22546693 | ||
| Pubmed | 8.97e-05 | 777 | 48 | 7 | 35844135 | ||
| Pubmed | 9.41e-05 | 332 | 48 | 5 | 37433992 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 9.41e-05 | 332 | 48 | 5 | 32786267 | |
| Pubmed | Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1. | 1.02e-04 | 11 | 48 | 2 | 37254794 | |
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 1.02e-04 | 11 | 48 | 2 | 10204490 | |
| Pubmed | Developmental basis for filamin-A-associated myxomatous mitral valve disease. | 1.02e-04 | 11 | 48 | 2 | 22843703 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 9885572 | ||
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 22560079 | ||
| Pubmed | 1.30e-04 | 1431 | 48 | 9 | 37142655 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.32e-04 | 357 | 48 | 5 | 37059091 | |
| Pubmed | 1.32e-04 | 1116 | 48 | 8 | 31753913 | ||
| Pubmed | 1.36e-04 | 1440 | 48 | 9 | 30833792 | ||
| Pubmed | 1.42e-04 | 191 | 48 | 4 | 33762435 | ||
| Pubmed | LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. | 1.44e-04 | 13 | 48 | 2 | 19703393 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 32151560 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 17360773 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 16428440 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 23584254 | ||
| Pubmed | NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. | 1.68e-04 | 14 | 48 | 2 | 25150861 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 20585571 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.75e-04 | 1489 | 48 | 9 | 28611215 | |
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 1.94e-04 | 15 | 48 | 2 | 35695185 | |
| Pubmed | Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. | 1.94e-04 | 15 | 48 | 2 | 9804427 | |
| Pubmed | NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. | 1.94e-04 | 15 | 48 | 2 | 19927129 | |
| Pubmed | 2.19e-04 | 214 | 48 | 4 | 22199357 | ||
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 21930775 | ||
| Pubmed | Rab40-Cullin5 complex regulates EPLIN and actin cytoskeleton dynamics during cell migration. | 2.21e-04 | 16 | 48 | 2 | 33999101 | |
| Pubmed | RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. | 2.21e-04 | 16 | 48 | 2 | 30760870 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 36709857 | ||
| Pubmed | 2.25e-04 | 85 | 48 | 3 | 19028597 | ||
| Pubmed | 2.42e-04 | 407 | 48 | 5 | 12693553 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 27806305 | ||
| Pubmed | 2.69e-04 | 653 | 48 | 6 | 22586326 | ||
| Pubmed | Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development. | 2.81e-04 | 18 | 48 | 2 | 23201013 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 9790534 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 12493763 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 16054041 | ||
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 10444591 | ||
| Pubmed | LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. | 2.81e-04 | 18 | 48 | 2 | 19497860 | |
| Pubmed | Binding specificity of Toll-like receptor cytoplasmic domains. | 3.14e-04 | 19 | 48 | 2 | 16482509 | |
| Pubmed | 3.50e-04 | 242 | 48 | 4 | 34011540 | ||
| Pubmed | 3.66e-04 | 1297 | 48 | 8 | 33545068 | ||
| Pubmed | 3.85e-04 | 21 | 48 | 2 | 12601173 | ||
| Pubmed | 3.96e-04 | 103 | 48 | 3 | 32744500 | ||
| Pubmed | 3.96e-04 | 103 | 48 | 3 | 21706016 | ||
| Pubmed | 4.19e-04 | 105 | 48 | 3 | 9628581 | ||
| Pubmed | 5.29e-04 | 1371 | 48 | 8 | 36244648 | ||
| Pubmed | 6.36e-04 | 503 | 48 | 5 | 16964243 | ||
| Pubmed | 6.54e-04 | 506 | 48 | 5 | 30890647 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.60e-04 | 774 | 48 | 6 | 15302935 | |
| Pubmed | 6.89e-04 | 28 | 48 | 2 | 28057766 | ||
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 7.46e-04 | 128 | 48 | 3 | 25332235 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 8.16e-04 | 132 | 48 | 3 | 16944949 | |
| Pubmed | 8.60e-04 | 538 | 48 | 5 | 28524877 | ||
| Pubmed | HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. | 9.01e-04 | 32 | 48 | 2 | 27114546 | |
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 9.58e-04 | 33 | 48 | 2 | 33567268 | |
| Pubmed | A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. | 1.02e-03 | 34 | 48 | 2 | 12577067 | |
| Pubmed | Identification of the BRD1 interaction network and its impact on mental disorder risk. | 1.08e-03 | 35 | 48 | 2 | 27142060 | |
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 1.14e-03 | 36 | 48 | 2 | 29089422 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.24e-03 | 1203 | 48 | 7 | 29180619 | |
| Pubmed | 1.24e-03 | 340 | 48 | 4 | 24332808 | ||
| Pubmed | 1.27e-03 | 38 | 48 | 2 | 31694235 | ||
| Pubmed | 1.27e-03 | 38 | 48 | 2 | 33283408 | ||
| Pubmed | 1.31e-03 | 591 | 48 | 5 | 15231748 | ||
| Cytoband | 13q22.2 | 2.99e-05 | 8 | 48 | 2 | 13q22.2 | |
| Cytoband | 12q14.2 | 1.44e-04 | 17 | 48 | 2 | 12q14.2 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.51e-04 | 12 | 28 | 2 | 1305 | |
| GeneFamily | PHD finger proteins | 3.57e-04 | 90 | 28 | 3 | 88 | |
| Coexpression | GSE17721_CTRL_VS_LPS_6H_BMDC_UP | 1.72e-06 | 200 | 48 | 6 | M3691 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP | 1.10e-05 | 160 | 48 | 5 | M7726 | |
| Coexpression | XIE_LT_HSC_S1PR3_OE_UP | 2.04e-05 | 29 | 48 | 3 | M41754 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-08 | 189 | 48 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 7.52e-08 | 200 | 48 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-06 | 170 | 48 | 5 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.61e-06 | 184 | 48 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-06 | 194 | 48 | 5 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-06 | 194 | 48 | 5 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.09e-06 | 194 | 48 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.19e-06 | 196 | 48 | 5 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.19e-06 | 196 | 48 | 5 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.30e-06 | 198 | 48 | 5 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.42e-06 | 200 | 48 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 152 | 48 | 4 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 154 | 48 | 4 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 2.28e-05 | 154 | 48 | 4 | 059bdf6843f94f5028d4df6aa025865a9edb4521 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-05 | 156 | 48 | 4 | fbe23876f0899853cea3c5c4f3044a9cea064d5b | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-05 | 156 | 48 | 4 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 164 | 48 | 4 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-05 | 165 | 48 | 4 | c39f0479955c4e23921f7a450d3bc251a002200f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.29e-05 | 169 | 48 | 4 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-05 | 169 | 48 | 4 | a83e4078db91ecedee637b28b12ec38640fe45f9 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 169 | 48 | 4 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.29e-05 | 169 | 48 | 4 | f914aa8899fa170a09da31e5fad86de897ea789b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.36e-05 | 170 | 48 | 4 | bf589c4297ccc90e5f51e3d0fcc229548af4fcef | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.36e-05 | 170 | 48 | 4 | df1a34a69ae404c56f00751a01f52359535f5469 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-05 | 174 | 48 | 4 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-05 | 174 | 48 | 4 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 177 | 48 | 4 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 178 | 48 | 4 | 8c5e9fab7b55a654ccaabf2c4d02397399d94616 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-05 | 179 | 48 | 4 | 33ed9270d257895ff3b40df2c1af878119c9f492 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-05 | 179 | 48 | 4 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 183 | 48 | 4 | f524501dec1dccbf44100a61395116e4525bdc89 | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.48e-05 | 183 | 48 | 4 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.67e-05 | 185 | 48 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 186 | 48 | 4 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.77e-05 | 186 | 48 | 4 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 187 | 48 | 4 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.87e-05 | 187 | 48 | 4 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.98e-05 | 188 | 48 | 4 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 188 | 48 | 4 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.08e-05 | 189 | 48 | 4 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.08e-05 | 189 | 48 | 4 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.18e-05 | 190 | 48 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 5.29e-05 | 191 | 48 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 191 | 48 | 4 | 51535232e889db52a9b24e5696b1687e93dd7302 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-05 | 191 | 48 | 4 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.29e-05 | 191 | 48 | 4 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.29e-05 | 191 | 48 | 4 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Club|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.40e-05 | 192 | 48 | 4 | 044c7ae56da17cacf2705efa8ac2c8aeba6cfeee | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.40e-05 | 192 | 48 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 18-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 5.40e-05 | 192 | 48 | 4 | 9fae988ecd2ef1231bfd42a678a4903517694cbe | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 5.51e-05 | 193 | 48 | 4 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-05 | 194 | 48 | 4 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.62e-05 | 194 | 48 | 4 | 0396457834bbfed8d0b9b2ddaaecd9f28e1d56ed | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 195 | 48 | 4 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | COVID-19-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 5.73e-05 | 195 | 48 | 4 | 9ad844d9d5aac39d133ae8ab9c4839300f08064c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.73e-05 | 195 | 48 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.73e-05 | 195 | 48 | 4 | 7b181e5b05becec3fd5031849affa9a135b26d3f | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.73e-05 | 195 | 48 | 4 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 196 | 48 | 4 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.93e-05 | 70 | 48 | 3 | e1ac00f4a519b6ada89f591e549874bd3eed0ca1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.93e-05 | 70 | 48 | 3 | 27e12c0f43a996bcbed285c5ee668bef5a786d80 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.93e-05 | 70 | 48 | 3 | b6815131e87e81c10e65bc398a84dab5a74b32ac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-05 | 197 | 48 | 4 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.97e-05 | 197 | 48 | 4 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-05 | 197 | 48 | 4 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.08e-05 | 198 | 48 | 4 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.08e-05 | 198 | 48 | 4 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 6.08e-05 | 198 | 48 | 4 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.08e-05 | 198 | 48 | 4 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.08e-05 | 198 | 48 | 4 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 6.08e-05 | 198 | 48 | 4 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | ASK452-Epithelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.20e-05 | 199 | 48 | 4 | e8778d4d2bc7e15b4c7989a93e5808a76738df46 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.20e-05 | 199 | 48 | 4 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 6.20e-05 | 199 | 48 | 4 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | 326cae37cacd94b423a6ac8873ea56c5abaf0a0b | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.33e-05 | 200 | 48 | 4 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | COVID-19_Convalescent-NK|COVID-19_Convalescent / Disease condition and Cell class | 6.33e-05 | 200 | 48 | 4 | dd62477b12c54065d4b70866c1523e9c217a48a9 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 110 | 48 | 3 | ff196c71aa2a21cdd812958bd163fa6b91bd2352 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 110 | 48 | 3 | 438bf761ab0a25e3dc9244c23ae2c2d68a169c7f | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 110 | 48 | 3 | 46635a130453c2fa304f0e09561b2a267c9ceb31 | |
| ToppCell | Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 110 | 48 | 3 | 3639fb5fc02eca509cb220295bc3e6064c23baab | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.23e-04 | 124 | 48 | 3 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.14e-04 | 135 | 48 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.32e-04 | 137 | 48 | 3 | 3218c787a6b087f74b0804cec14b5ebb713391b7 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.52e-04 | 149 | 48 | 3 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 5.74e-04 | 151 | 48 | 3 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.85e-04 | 152 | 48 | 3 | aa88084ba1851d879ece82baa516f6b46cbd2eb8 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-04 | 152 | 48 | 3 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-04 | 152 | 48 | 3 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| Disease | Periventricular Heterotopia, X-Linked | 6.82e-06 | 3 | 45 | 2 | C1848213 | |
| Disease | Bilateral Periventricular Nodular Heterotopia | 6.82e-06 | 3 | 45 | 2 | C4551969 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 3.40e-05 | 6 | 45 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 4.75e-05 | 7 | 45 | 2 | C1868720 | |
| Disease | Epileptic encephalopathy | 9.63e-04 | 30 | 45 | 2 | C0543888 | |
| Disease | white matter hyperintensity measurement | 1.15e-03 | 302 | 45 | 4 | EFO_0005665 | |
| Disease | Kartagener Syndrome | 1.31e-03 | 35 | 45 | 2 | C0022521 | |
| Disease | Polynesian Bronchiectasis | 1.31e-03 | 35 | 45 | 2 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.31e-03 | 35 | 45 | 2 | C4551906 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSFQKERTDDEQFAD | 306 | Q9H9S4 | |
| AFEFLDNEREFISRE | 86 | A0FGR9 | |
| DDDDFETNFLIDRNF | 301 | Q8NFU1 | |
| TDGSFQDRFREFEDS | 2516 | P13611 | |
| QNDEFDVFSRDSVDL | 541 | Q9H1I8 | |
| DERDNFVQNDFRDPD | 206 | Q8N0V3 | |
| SSLEEDAEDFFFTAR | 6 | Q86WH2 | |
| EERDDSLRFNENITF | 346 | O60268 | |
| AFRRFEDFTRNFDEV | 1371 | O00763 | |
| NLQSRFEDFLEDSQE | 1011 | Q03001 | |
| DRLEELREFANFDFD | 7171 | Q03001 | |
| RAFEDFRKFSEQDDS | 531 | Q8WWI1 | |
| RDQFQIRENDFLTFD | 641 | P18074 | |
| AVEDFCNNFRDFIER | 151 | Q9Y4A0 | |
| FSARCFLDQFEDDAD | 906 | O94988 | |
| ADFNLQDFRDTVDDL | 111 | D6RGH6 | |
| FEFQNFERRFEECIS | 336 | O95140 | |
| FTDDCKFRERFQENS | 156 | P12034 | |
| QDRDFLENEQFFLET | 1106 | Q8TES7 | |
| DFEDTEVRRSNFDNF | 586 | Q13698 | |
| DIDFDIIRNDNDTFT | 821 | P21333 | |
| REAFEAASREDFELQ | 41 | Q9UBR1 | |
| DSRAIIRENEFSFED | 821 | Q12873 | |
| NQLRETFDFDDDCDS | 366 | Q5TF58 | |
| SEQQFRVFRDFDFLD | 2451 | Q5TBA9 | |
| DSRAIIRENEFSFED | 811 | Q14839 | |
| FSDDFSDDFVETRRR | 1191 | Q96T23 | |
| DIFRDFGNNEEDFLT | 71 | Q9P1A2 | |
| LNFQEDDDTSRETFA | 341 | Q9H814 | |
| FELQDDFSEFLDSRV | 41 | Q9C093 | |
| DDQDFRSFRSECEAE | 26 | Q9Y365 | |
| EFTNNRRCFEEDFKT | 76 | Q9ULQ0 | |
| EEFGDFRLVSNDNEF | 996 | Q9HAW4 | |
| FRLVSNDNEFDSDED | 1001 | Q9HAW4 | |
| NTLLNFTDNFDDFRR | 1376 | Q63HN8 | |
| FTDNFDDFRRETLDQ | 1381 | Q63HN8 | |
| EDFQEFQTQNFDRFD | 946 | P35443 | |
| FQETFEDVFSDRSLR | 86 | P13686 | |
| FEDSRAEDKRSFFQD | 1271 | Q5JSZ5 | |
| TDDDFERSRAFNFLN | 66 | P51809 | |
| LEDSGFDEQQEFRSR | 301 | O60343 | |
| FAFQEDDSFEKENRS | 321 | Q6P444 | |
| FCTFEEAREAFENNE | 41 | O14668 | |
| FFSIDQEEDVDFLAR | 276 | O43592 | |
| NDAFENFALDFSREK | 376 | Q9UJV3 | |
| ERQDKDFSFDQSERQ | 186 | Q6XPR3 | |
| DQNRFNLCFEERDFV | 721 | O60602 | |
| SELFEAFDLFDVRDF | 91 | Q9UKW4 | |
| ELETREFFTDADFQD | 591 | Q9C099 | |
| TRQDDFFILQEDAAD | 826 | O00160 | |
| FEVFDENRLTRDDFL | 91 | Q96PU5 |